Reconstruction of Myerson type III chronic Achilles tendon ruptures using semitendinosus tendon and gracilis tendon autograft

Journal of Orthopaedic Surgery
Xian-Jun JiangPei-Jian Tong

Abstract

Reconstruction of Myerson type III (defect size more than 5 cm) chronic Achilles tendon ruptures (CATRs) is a surgical challenge due to its large Achilles tendon defect. This study aims to describe our operative technique for Myerson type III CATR and its clinical outcomes. From May 2012 to April 2015, we treated seven patients (6 males, 1 female) with Myerson type III CATR using semitendinosus tendon and gracilis tendon autograft. The mean age was 47.3 years (range: 37-56). Patients were followed for a mean time of 31.3 months. All patients' defect size between Achilles ends after debridement was more than 5 cm and hence classified as Myerson type III. The clinical outcomes were evaluated by visual analog scale (VAS) for pain, American Orthopaedic Foot and Ankle Society (AOFAS) ankle and hindfoot score, Achilles tendon total rupture score (ATRS), and the Short Form 36 (SF-36). All patients reported good postoperative clinical outcomes. The average AOFAS score increased from 54.29 points (range: 46-65 points) preoperatively to 97.57 points (range: 90-100 points) at last follow-up. The average ATRS increased from 51.43 points (range: 40-61 points) preoperatively to 92.71 points (range: 83-100 points) at last follow-up. And the a...Continue Reading

References

Mar 23, 2005·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Nicola Maffulli, Wayne B Leadbetter
Dec 13, 2006·The American Journal of Sports Medicine·Katarina Nilsson-HelanderJon Karlsson
Oct 10, 2007·Foot & Ankle International·Jong Hun JiJong Seoung Yoon
Nov 6, 2007·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Daniel K Lee
Nov 13, 2007·Foot and Ankle Clinics·Nicola MaffulliVincenzo Denaro
Feb 26, 2010·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Mahmut Nedim DoralNicola Maffulli
Oct 12, 2012·International Orthopaedics·Björn BareniusJulian Feller
Apr 12, 2014·Foot & Ankle International·Sampat Shivajirao Dumbre PatilAjay Birappa Dombale
Feb 24, 2015·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Ann GanestamKristoffer Weisskirchner Barfod
Oct 18, 2016·Indian Journal of Orthopaedics·Xudong MiaoLu Huang
Mar 17, 2017·The American Journal of Sports Medicine·Cale A JacobsDarren L Johnson
May 30, 2017·Foot & Ankle International·Matthew J KraeutlerKenneth J Hunt
Sep 4, 2017·Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons·Ahmed Shoaib, Viren Mishra
Nov 5, 2017·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Daniel B HaberElizabeth G Matzkin
Feb 8, 2018·Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons·Nicola MaffulliNikolaos Gougoulias
Aug 30, 2018·The Journal of the American Academy of Orthopaedic Surgeons·Karl M SchweitzerSamuel B Adams

❮ Previous
Next ❯

Citations

Oct 14, 2019·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Paweł BąkowskiTomasz Piontek
Dec 11, 2020·Journal of the American Podiatric Medical Association·Nicola MaffulliAntti J Stenroos
May 8, 2021·World Journal of Orthopedics·Hisatoshi IshikuraSakae Tanaka
Jun 6, 2021·International Orthopaedics·Zaki ArshadManeesh Bhatia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.